Goldman Sachs’s SBC Medical Group SBC Stock Holding History

Goldman Sachs’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Buy	25,087 +13,764	+122%	+$57.4K	﹤0.01%	6203
2025 Q4	$48.8K	Buy	+11,323	New	+$43.2K	﹤0.01%	6290

Other funds holding SBC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Goldman Sachs's SBC Position: Q1 2026 in Review

Goldman Sachs increased its SBC Medical Group (SBC) stake by 122% in Q1 2026, buying an estimated $57.4K and bringing the position to 25,087 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #6203.

Goldman Sachs first reported a position in SBC in Q4 2025 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

Goldman Sachs held 25,087 shares of SBC Medical Group worth $105K as of Q1 2026.
Goldman Sachs bought 13,764 SBC Medical Group shares in Q1 2026, an estimated $57.4K.
SBC Medical Group made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6203 holding.
Goldman Sachs first reported a position in SBC Medical Group in Q4 2025 and has held it in 2 quarters since.
50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.